- Community Update: New Drugs to Watch
A report on two recent conferences summarized some of the most important treatment changes today, new drugs in the pipeline especially for patients who have already failed many antiretrovirals, and current treatment philosophies and challenges for AIDS medicine and research.
- Nevirapine (Viramune®) Strengthens Warning on Liver, Skin Toxicities
A recent letter to doctors strengthened the U.S. warnings and precautions on using this antiretroviral (which has been approved and in widespread use for years), due to serious complications in a small minority of patients; the point of the changes is to catch such problems and stop the drug in time. Patients obtaining refills or new prescriptions should in the future receive a "patient package insert," dated November 2000, based on the new warnings.
- "Trizivir" Approved: Three Existing Drugs in One
New approval combines AZT, 3TC, and abacavir in one pill.
- Nutrition and HIV Infection: Experience in Zimbabwe -- Interview with Lynde Francis
For years Lynde Francis has run an AIDS service organization in Harare, Zimbabwe, where few patients can afford antiretrovirals, so nutritional improvement is often the only treatment available. In this interview she explains what she has found to be helpful. While specific nutritional advice will vary, depending on many factors, we believe that readers should be aware of this treatment experience.
- AIDS Treatment News Will Move to Philadelphia on January 2
At the end of this year AIDS Treatment News will move to Philadelphia to work with Philadelphia FIGHT, a well-known AIDS treatment, research, and education organization. Our policies and publication schedule will remain the same, and readers will see little immediate change except for the address.
ISSN # 1052-4207
Copyright 2000 by John S. James. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used.